Logo image of CXT

CRANE NXT CO (CXT) Stock Fundamental Analysis

USA - New York Stock Exchange - NYSE:CXT - US2244411052 - Common Stock

47.7051 USD
-0.21 (-0.45%)
Last: 12/23/2025, 10:56:44 AM
Fundamental Rating

5

Overall CXT gets a fundamental rating of 5 out of 10. We evaluated CXT against 124 industry peers in the Electronic Equipment, Instruments & Components industry. CXT has an excellent profitability rating, but there are concerns on its financial health. CXT scores decently on growth, while it is valued quite cheap. This could make an interesting combination.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

CXT had positive earnings in the past year.
CXT had a positive operating cash flow in the past year.
Each year in the past 5 years CXT has been profitable.
CXT had a positive operating cash flow in each of the past 5 years.
CXT Yearly Net Income VS EBIT VS OCF VS FCFCXT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 100M 200M 300M

1.2 Ratios

The Return On Assets of CXT (5.30%) is better than 70.16% of its industry peers.
CXT has a better Return On Equity (12.74%) than 79.03% of its industry peers.
With a decent Return On Invested Capital value of 8.69%, CXT is doing good in the industry, outperforming 77.42% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for CXT is above the industry average of 9.32%.
The last Return On Invested Capital (8.69%) for CXT is well below the 3 year average (13.27%), which needs to be investigated, but indicates that CXT had better years and this may not be a problem.
Industry RankSector Rank
ROA 5.3%
ROE 12.74%
ROIC 8.69%
ROA(3y)8.73%
ROA(5y)6.81%
ROE(3y)20.99%
ROE(5y)16.9%
ROIC(3y)13.27%
ROIC(5y)10.31%
CXT Yearly ROA, ROE, ROICCXT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 5 10 15 20 25

1.3 Margins

CXT has a Profit Margin of 9.80%. This is amongst the best in the industry. CXT outperforms 80.65% of its industry peers.
CXT's Profit Margin has declined in the last couple of years.
CXT has a better Operating Margin (17.59%) than 92.74% of its industry peers.
CXT's Operating Margin has been stable in the last couple of years.
The Gross Margin of CXT (43.20%) is better than 75.00% of its industry peers.
CXT's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 17.59%
PM (TTM) 9.8%
GM 43.2%
OM growth 3Y1.32%
OM growth 5YN/A
PM growth 3Y-2.19%
PM growth 5YN/A
GM growth 3Y0.16%
GM growth 5YN/A
CXT Yearly Profit, Operating, Gross MarginsCXT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 10 20 30 40

2

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), CXT is creating some value.
The number of shares outstanding for CXT has been increased compared to 1 year ago.
CXT has a worse debt/assets ratio than last year.
CXT Yearly Shares OutstandingCXT Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
CXT Yearly Total Debt VS Total AssetsCXT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.2 Solvency

An Altman-Z score of 2.05 indicates that CXT is not a great score, but indicates only limited risk for bankruptcy at the moment.
CXT has a Altman-Z score of 2.05. This is in the lower half of the industry: CXT underperforms 69.35% of its industry peers.
CXT has a debt to FCF ratio of 6.27. This is a slightly negative value and a sign of low solvency as CXT would need 6.27 years to pay back of all of its debts.
CXT's Debt to FCF ratio of 6.27 is in line compared to the rest of the industry. CXT outperforms 57.26% of its industry peers.
CXT has a Debt/Equity ratio of 0.89. This is a neutral value indicating CXT is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.89, CXT is doing worse than 87.90% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.89
Debt/FCF 6.27
Altman-Z 2.05
ROIC/WACC0.98
WACC8.89%
CXT Yearly LT Debt VS Equity VS FCFCXT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 500M 1B 1.5B

2.3 Liquidity

A Current Ratio of 1.26 indicates that CXT should not have too much problems paying its short term obligations.
CXT's Current ratio of 1.26 is on the low side compared to the rest of the industry. CXT is outperformed by 83.87% of its industry peers.
CXT has a Quick Ratio of 1.26. This is a bad value and indicates that CXT is not financially healthy enough and could expect problems in meeting its short term obligations.
CXT's Quick ratio of 0.94 is on the low side compared to the rest of the industry. CXT is outperformed by 83.06% of its industry peers.
Industry RankSector Rank
Current Ratio 1.26
Quick Ratio 0.94
CXT Yearly Current Assets VS Current LiabilitesCXT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 500M 1B 1.5B

4

3. Growth

3.1 Past

The earnings per share for CXT have decreased by -1.72% in the last year.
Measured over the past years, CXT shows a decrease in Earnings Per Share. The EPS has been decreasing by -6.61% on average per year.
Looking at the last year, CXT shows a quite strong growth in Revenue. The Revenue has grown by 9.30% in the last year.
CXT shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.39% yearly.
EPS 1Y (TTM)-1.72%
EPS 3Y-13.64%
EPS 5Y-6.61%
EPS Q2Q%10.34%
Revenue 1Y (TTM)9.3%
Revenue growth 3Y3.39%
Revenue growth 5YN/A
Sales Q2Q%10.31%

3.2 Future

CXT is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 8.23% yearly.
CXT is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.34% yearly.
EPS Next Y-4.27%
EPS Next 2Y4.99%
EPS Next 3Y8.23%
EPS Next 5YN/A
Revenue Next Year9.22%
Revenue Next 2Y8.06%
Revenue Next 3Y7.34%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CXT Yearly Revenue VS EstimatesCXT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1B 2B 3B
CXT Yearly EPS VS EstimatesCXT Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2 4 6

7

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 11.96, which indicates a very decent valuation of CXT.
91.13% of the companies in the same industry are more expensive than CXT, based on the Price/Earnings ratio.
CXT's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 26.61.
CXT is valuated reasonably with a Price/Forward Earnings ratio of 10.14.
CXT's Price/Forward Earnings ratio is rather cheap when compared to the industry. CXT is cheaper than 91.13% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 24.01. CXT is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 11.96
Fwd PE 10.14
CXT Price Earnings VS Forward Price EarningsCXT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CXT is valued cheaper than 91.13% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, CXT is valued cheaply inside the industry as 87.90% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 15.87
EV/EBITDA 8.98
CXT Per share dataCXT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20

4.3 Compensation for Growth

CXT has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y4.99%
EPS Next 3Y8.23%

6

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 1.46%, CXT has a reasonable but not impressive dividend return.
In the last 3 months the price of CXT has falen by -26.36%. A price decline artificially increases the dividend yield. It may be a sign investors do not expect the dividend to last.
CXT's Dividend Yield is rather good when compared to the industry average which is at 0.47. CXT pays more dividend than 92.74% of the companies in the same industry.
Compared to the average S&P500 Dividend Yield of 1.87, CXT is paying slightly less dividend.
Industry RankSector Rank
Dividend Yield 1.46%

5.2 History

On average, the dividend of CXT grows each year by 6.42%, which is quite nice.
CXT has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)6.42%
Div Incr Years0
Div Non Decr Years0
CXT Yearly Dividends per shareCXT Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

24.82% of the earnings are spent on dividend by CXT. This is a low number and sustainable payout ratio.
The dividend of CXT is growing, but earnings are growing more, so the dividend growth is sustainable.
DP24.82%
EPS Next 2Y4.99%
EPS Next 3Y8.23%
CXT Yearly Income VS Free CF VS DividendCXT Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M
CXT Dividend Payout.CXT Dividend Payout, showing the Payout Ratio.CXT Dividend Payout.PayoutRetained Earnings

CRANE NXT CO

NYSE:CXT (12/23/2025, 10:56:44 AM)

47.7051

-0.21 (-0.45%)

Chartmill FA Rating
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)11-05 2025-11-05/amc
Earnings (Next)02-10 2026-02-10/amc
Inst Owners114.48%
Inst Owner ChangeN/A
Ins Owners0.24%
Ins Owner Change1.75%
Market Cap2.74B
Revenue(TTM)1.58B
Net Income(TTM)154.70M
Analysts81.82
Price Target95.15 (99.45%)
Short Float %14%
Short Ratio14.77
Dividend
Industry RankSector Rank
Dividend Yield 1.46%
Yearly Dividend0.64
Dividend Growth(5Y)6.42%
DP24.82%
Div Incr Years0
Div Non Decr Years0
Ex-Date11-28 2025-11-28 (0.17)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)0.72%
Min EPS beat(2)0.03%
Max EPS beat(2)1.41%
EPS beat(4)3
Avg EPS beat(4)1.08%
Min EPS beat(4)-1.06%
Max EPS beat(4)3.95%
EPS beat(8)6
Avg EPS beat(8)1.32%
EPS beat(12)10
Avg EPS beat(12)6.53%
EPS beat(16)13
Avg EPS beat(16)6.15%
Revenue beat(2)1
Avg Revenue beat(2)-0.28%
Min Revenue beat(2)-2.45%
Max Revenue beat(2)1.89%
Revenue beat(4)2
Avg Revenue beat(4)-0.1%
Min Revenue beat(4)-2.54%
Max Revenue beat(4)2.69%
Revenue beat(8)4
Avg Revenue beat(8)0.56%
Revenue beat(12)6
Avg Revenue beat(12)0.73%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)3.49%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-5.78%
EPS NY rev (1m)-1.53%
EPS NY rev (3m)-1.49%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)1.93%
Revenue NY rev (1m)1.54%
Revenue NY rev (3m)1.6%
Valuation
Industry RankSector Rank
PE 11.96
Fwd PE 10.14
P/S 1.73
P/FCF 15.87
P/OCF 12.63
P/B 2.26
P/tB N/A
EV/EBITDA 8.98
EPS(TTM)3.99
EY8.36%
EPS(NY)4.71
Fwd EY9.87%
FCF(TTM)3.01
FCFY6.3%
OCF(TTM)3.78
OCFY7.91%
SpS27.5
BVpS21.14
TBVpS-9.06
PEG (NY)N/A
PEG (5Y)N/A
Graham Number43.57
Profitability
Industry RankSector Rank
ROA 5.3%
ROE 12.74%
ROCE 12.04%
ROIC 8.69%
ROICexc 9.36%
ROICexgc 34.76%
OM 17.59%
PM (TTM) 9.8%
GM 43.2%
FCFM 10.93%
ROA(3y)8.73%
ROA(5y)6.81%
ROE(3y)20.99%
ROE(5y)16.9%
ROIC(3y)13.27%
ROIC(5y)10.31%
ROICexc(3y)14.97%
ROICexc(5y)11.69%
ROICexgc(3y)57.83%
ROICexgc(5y)41.66%
ROCE(3y)18.35%
ROCE(5y)14.1%
ROICexgc growth 3Y39.7%
ROICexgc growth 5YN/A
ROICexc growth 3Y25.58%
ROICexc growth 5YN/A
OM growth 3Y1.32%
OM growth 5YN/A
PM growth 3Y-2.19%
PM growth 5YN/A
GM growth 3Y0.16%
GM growth 5YN/A
F-Score3
Asset Turnover0.54
Health
Industry RankSector Rank
Debt/Equity 0.89
Debt/FCF 6.27
Debt/EBITDA 2.86
Cap/Depr 43.72%
Cap/Sales 2.8%
Interest Coverage 5.31
Cash Conversion 57.22%
Profit Quality 111.57%
Current Ratio 1.26
Quick Ratio 0.94
Altman-Z 2.05
F-Score3
WACC8.89%
ROIC/WACC0.98
Cap/Depr(3y)39.82%
Cap/Depr(5y)33.75%
Cap/Sales(3y)2.29%
Cap/Sales(5y)1.89%
Profit Quality(3y)120.27%
Profit Quality(5y)131.76%
High Growth Momentum
Growth
EPS 1Y (TTM)-1.72%
EPS 3Y-13.64%
EPS 5Y-6.61%
EPS Q2Q%10.34%
EPS Next Y-4.27%
EPS Next 2Y4.99%
EPS Next 3Y8.23%
EPS Next 5YN/A
Revenue 1Y (TTM)9.3%
Revenue growth 3Y3.39%
Revenue growth 5YN/A
Sales Q2Q%10.31%
Revenue Next Year9.22%
Revenue Next 2Y8.06%
Revenue Next 3Y7.34%
Revenue Next 5YN/A
EBIT growth 1Y-0.68%
EBIT growth 3Y4.76%
EBIT growth 5YN/A
EBIT Next Year18.99%
EBIT Next 3Y14.2%
EBIT Next 5YN/A
FCF growth 1Y-55.34%
FCF growth 3Y-13.25%
FCF growth 5YN/A
OCF growth 1Y-48.89%
OCF growth 3Y-8.23%
OCF growth 5YN/A

CRANE NXT CO / CXT FAQ

What is the fundamental rating for CXT stock?

ChartMill assigns a fundamental rating of 5 / 10 to CXT.


What is the valuation status for CXT stock?

ChartMill assigns a valuation rating of 7 / 10 to CRANE NXT CO (CXT). This can be considered as Undervalued.


What is the profitability of CXT stock?

CRANE NXT CO (CXT) has a profitability rating of 7 / 10.


Can you provide the PE and PB ratios for CXT stock?

The Price/Earnings (PE) ratio for CRANE NXT CO (CXT) is 11.96 and the Price/Book (PB) ratio is 2.26.


What is the expected EPS growth for CRANE NXT CO (CXT) stock?

The Earnings per Share (EPS) of CRANE NXT CO (CXT) is expected to decline by -4.27% in the next year.